In line, various analyses have demonstrated that elevated concentrations of the C-reactive protein are associated with colorectal cancer, pancreatic cancer, endometrial malignancies, and melanoma as well as postmenopausal breast cancer and are useful to indicate treatment resistance and/or survival [20]. This evidence concerns the gene CRP and breast cancer.